Benefit of Risk-stratified Prophylactic Treatment on Clinical Outcome in Postoperative Crohn's Disease.
Journal Information
Full Title: J Crohns Colitis
Abbreviation: J Crohns Colitis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Gastroenterology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of Interest VJ, JS, EW MD, JJ, JB, AM, WL, WB, CB, GD: none to declare. NdB has served as a speaker for AbbVie and MSD and has served as consultant and/or principal investigator for TEVA Pharma BV and Takeda. He has received [unrestricted] research grant from Dr Falk, TEVA Pharma BV, MLDS, and Takeda, all outside the submitted work."
"Funding The authors received no financial support for research, authorship, and/or publication of this article."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025